CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib

Saved in:
Bibliographic Details
Published in:Value in health 2024-06, Vol.27 (6), p.S20-S20
Main Authors: Desai, J., Wagner, AJ, Carrasco, Garcia I., Cesari, M., Gordon, M., Lin, CC, Papai, Z., Ryan, CW, Tap, WD, Trent, JC, Gelderblom, H., Grimison, P., López, Pousa A., Tine, Van, Dai, D., Rubinacci, M., Tecson, K., Wooddell, M., Stacchiotti, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2024.03.111